Obesity and breast cancer: A complex relationship

被引:11
|
作者
Gershuni V.M. [1 ]
Ahima R.S. [2 ]
Tchou J. [3 ]
机构
[1] Department of Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, 19104, PA
[2] Department of Endocrinology, Diabetes and Metabolism Division, Hospital of the University of Pennsylvania, 3400 Civic Center Boulevard, Building 421, Philadelphia, 19104, PA
[3] Department of Surgery Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine, 34th & Civic Center Blvd, 3 South, Philadelphia, 19104, PA
关键词
Adipocyte; Adipokines; Adiponectin; Aromatase; BMI; Breast cancer; Estrogen receptor Leptin; Hyperglycemia; Hyperinsulinemia; Inflammation; Insulin resistance; Metabolic syndrome; Obesity; Overweight;
D O I
10.1007/s40137-016-0134-5
中图分类号
学科分类号
摘要
As prevalence of obesity continues to rise in the United States, we are beginning to elucidate the complex role of obesity-associated chronic inflammation, endocrine dysfunction, and hormone production as a driver for increased breast cancer risk. Epidemiological data suggest that obesity (BMI [ 30) is associated with increased breast cancer incidence, worse prognosis, and higher mortality rates. Mechanistically, obesity and excess fat mass represent a state of chronic inflammation, insulin resistance, adipokine imbalance, and increased estrogen signaling. This pro-tumorigenic environment stimulates cancer development through abnormal growth, proliferation, and survival of mammary tissue. Importantly, obesity is a modifiable risk factor; alterations in cell proliferation, apoptosis, circulating estrogen, and insulin sensitivity are observed in response to weight loss attainable through behavior modification including dietary and exercise changes. © Springer Science + Business Media New York 2016.
引用
收藏
相关论文
共 50 条
  • [1] Obesity and Cathepsin K: A Complex Pathophysiological Relationship in Breast Cancer Metastases
    Vashum, Yaongamphi
    Khashim, Zenith
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (08) : 1227 - 1231
  • [2] Obesity-associated Breast Cancer: Analysis of risk factors
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 571 - 606
  • [3] The Impact of Obesity on Breast Cancer
    Argolo, Daniel F.
    Hudis, Clifford A.
    Iyengar, Neil M.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (06)
  • [4] The Impact of Obesity on Breast Cancer
    Daniel F. Argolo
    Clifford A. Hudis
    Neil M. Iyengar
    Current Oncology Reports, 2018, 20
  • [5] Influence of obesity on breast cancer receptor status and prognosis
    Rose, David P.
    Vona-Davis, Linda
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (08) : 1091 - 1101
  • [6] Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
    Kolb, Ryan
    Zhang, Weizhou
    CANCERS, 2020, 12 (06) : 1 - 18
  • [7] Hormonal Mechanisms Underlying the Relationship Between Obesity and Breast Cancer
    Perks, Claire M.
    Holly, Jeff M. P.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (03) : 485 - +
  • [8] Adipokine leptin in obesity-related pathology of breast cancer
    Ray, Amitabha
    JOURNAL OF BIOSCIENCES, 2012, 37 (02) : 289 - 294
  • [9] Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
    Ando, Sebastiano
    Gelsomino, Luca
    Panza, Salvatore
    Giordano, Cinzia
    Bonofiglio, Daniela
    Barone, Ines
    Catalano, Stefania
    CANCERS, 2019, 11 (01)
  • [10] OBESITY AND CANCER: AN UNDERESTIMATED TOXIC RELATIONSHIP
    Talib, Wamidh H.
    Al Marjani, Mohammed F.
    Alnatour, Dalal
    Abuelshayeb, Leedia
    Abu Rayan, Abdullah J.
    Mahmod, Asma Ismail
    FARMACIA, 2023, 71 (03) : 441 - 454